Advocacy intelligence hub — real-time data for patient organizations
European Organisation for Research and Treatment of Cancer - EORTC — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Adcetris
(brentuximab vedotin)Orphan drugstandardSeagen Inc.
CD30-directed Immunoconjugate [EPC]
12.1 Mechanism of Action CD30 is a member of the tumor necrosis factor receptor family and is expressed on the surface of sALCL cells and on Hodgkin R...
Browse all Primary cutaneous anaplastic large cell lymphoma news →
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Ryotaro Nakamura
City of Hope Medical Center
📍 Duarte, California
Ann (Annie) W Silk
Dana-Farber - Harvard Cancer Center LAO
📍 Los Angeles, California
Thomas E. Witzig, MD, M.D
Mayo Clinic
📍 ROCHESTER, MN
George Chen
Roswell Park Cancer Institute
View all Primary cutaneous anaplastic large cell lymphoma specialists →